John A. Ballantyne Revocable Living Trust dated 08/01/2017 - 30 Jul 2024 Form 3 Insider Report for Glucotrack, Inc. (GCTK)

Role
10%+ Owner
Signature
/s/ Nelson Mullins Riley & Scarborough LLP, Attorney-in-Fact
Issuer symbol
GCTK
Transactions as of
30 Jul 2024
Net transactions value
$0
Form type
3
Filing time
28 Mar 2025, 20:31:22 UTC
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding GCTK Common Stock, par value $0.001 per share 51,002 30 Jul 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 John A. Ballantyne is the trustee of the reporting person and has sole voting and investment power over all securities owned by the reporting person.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney Note: On May 17, 2024, a 1-for-5 reverse stock split of the Issuer's common stock, par value $0.001 per share (the "Common Stock") was implemented (the "2024 Reverse Split"). On February 25, 2025, a 1-for-20 reverse stock split of the Common Stock was implemented (the "2025 Reverse Split," and together with the 2024 Reverse Split, the "Reverse Stock Splits"). All figures presented in this Form 3 reflect the Reverse Stock Splits.